Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion

Area of Science:

• Cardiology
• Toxicology
• Pharmacology

Background:

• Stone heart syndrome, a rare condition, presents unique challenges in clinical management.
• Digoxin toxicity is a known complication that requires careful monitoring and treatment.
• The interaction between these conditions and calcium administration is not fully understood.

Observation:

• Theoretically, intravenous calcium administration could exacerbate the cardiac effects of digoxin toxicity.
• Existing research on this specific interaction yields conflicting results.
• Clinical practice requires a cautious approach due to the uncertain outcomes.

Findings:

• Conflicting evidence exists regarding the safety and efficacy of intravenous calcium in stone heart syndrome with digoxin toxicity.
• The theoretical risk of worsening the condition necessitates further investigation.
• A definitive consensus on managing this patient population is lacking.

Implications:

• Clinicians must exercise extreme caution when considering intravenous calcium for patients with stone heart syndrome and digoxin toxicity.
• Further research is crucial to clarify the risks and benefits of calcium administration in this context.
• This highlights the need for evidence-based guidelines in managing complex cardiovascular emergencies.